News

Filter

1 to 9 of 97192 results

FDA approves Alcon’s Xtoro to treat swimmer’s ear

18-12-2014

The US Food and Drug Administration today approved Xtoro (finafloxacin otic suspension), a new drug used…

Acute otitis externaAlcon LaboratoriesAntibiotics and Infectious diseasesHealthNovartisPharmaceuticalRegulationUSAXtoro

Amgen reveals Blincyto price as $178,000 per course

Amgen reveals Blincyto price as $178,000 per course

18-12-2014

USA-based Amgen has revealed its intended pricing for its immunotherapy Blincyto (blinatumomab), which…

AmgenBiotechnologyBlincytoOncologyPricingUSA

Colorectal cancer market in Asia-Pacific region set to reach $3 billion by 2020; report

18-12-2014

The Colorectal Cancer (CRC) therapeutics market in Asia-Pacific (APAC) is set to increase in value, from…

AmgenAsia-PacificBiotechnologyDanDrit BiotechEli LillyMarkets & MarketingMelCancerVacOncologyVectibixXBiotechXilonix

X-Chem licenses second cardiovascular drug discovery program to Bayer

X-Chem licenses second cardiovascular drug discovery program to Bayer

18-12-2014

Privately-held biotech firm X-Chem has licensed a second drug discovery program to German pharma major…

BayerBiotechnologyCardio-vascularLicensingX-Chem

Orexo gets £5 million milestone for Abstral in Europe; Zubsolv continues strong growth in the USA

Orexo gets £5 million milestone for Abstral in Europe; Zubsolv continues strong growth in the USA

18-12-2014

The annual sales in Europe of Abstral, a rapidly-disintegrating, sublingual formulation of fentanyl,…

AbstralFinancialKyowa Hakko KirinLicensingNeurologicalOrexoPharmaceuticalProStrakanZubsolv

Insulin therapeutics specialist Nutrinia completes $12 million financing round

Insulin therapeutics specialist Nutrinia completes $12 million financing round

18-12-2014

Nutrinia, a developer of oral insulin therapies to treat rare gastrointestinal disorders in babies, has…

Business FinanceEndocrine systemGastro-intestinalsNutriniaPharmaceutical

Eisai's Halaven now available in Russia for advanced breast cancer

Eisai's Halaven now available in Russia for advanced breast cancer

18-12-2014

Halaven (eribulin) manufactured by Japanese drug major Eisai is now available in Russia.

EisaiHalavenOncologyPharmaceuticalRegulationRussia

Celgene appoints Marie-France Tschudin and Stefano Portolano to EMEA team

Celgene appoints Marie-France Tschudin and Stefano Portolano to EMEA team

18-12-2014

US biotech company Celgene Corp has made two appointments to its EMEA team.

BiotechnologyBoardroomCelgene CorpCelgene Corp.Stefano Portolano

1 to 9 of 97192 results

Back to top